beta

BMY

Bristol-Myers Squibb Co.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

Market Cap: 108 Billion

Primary Exchange: NEW YORK STOCK EXCHANGE INC.

Website: https://www.bms.com/

Shares Outstanding: 2.02 Billion

Float: 0

Dividend: 2.274147016134742 (0.04%)

Beta: 0.4464566379043942

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 1713 trading days

From: 2016-07-14 To: 2022-04-06

Lowest Point:

Bristol-Myers Squibb Announces Dividend

via: Business Wire at 2019-06-13 12:38:00:000

The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty one cents ($0.41) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on August 1, 2019, to stockholders of record at the … read more...

New Mechanistic Study Explores the Relationship Between a Key Genetic Marker and Clinical Efficacy of ORENCIA® (abatacept) or adalimumab in Moderate-to-Severe Early Rheumatoid Arthritis Patients

via: Business Wire at 2019-06-13 12:30:00:000

Findings from head-to-head Early AMPLE study are consistent with earlier studies, adding to body of research showing differences between mechanisms of biologic therapies Results suggest that a genetic marker linked to autoantibody production and a more severe RA disease course &#x20… read more...

Akero Therapeutics Readies $75 Million IPO

via: SeekingAlpha at 2019-06-13 09:11:26:000

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...

BIIB Is For Buy-O-Gen

via: SeekingAlpha at 2019-06-12 06:30:36:000

Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...

Iovance Makes Significant Impact At ASCO 2019 Conference With Cancer Drug

via: SeekingAlpha at 2019-06-11 10:52:56:000

Iovance Biotherapeutics ( IOVA ) had made a very large impact at ASCO 2019 and it was one of the clear winners for the medical conference. That's because it reported positive results from two of its studies. The positive results were made possible through the use of the biotech's Tumor infil… read more...

Week In Review: Frontage, A U.S.-China CRO, Stages $205 Million Hong Kong IPO

via: SeekingAlpha at 2019-06-10 00:47:20:000

Deals and Financings Frontage Holdings, a US-China CRO, raised $205 million in a Hong Kong IPO at a market capitalization of $820 million. It moved 4.5% higher on its first day of trading. According to Frontage, it will allocate 20% of the proceeds to meet increased demand, 40% for organic e… read more...

Chewy IPO, Lululemon And Tesla On Tap (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-06-09 03:30:00:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks.. If you are interested in listening to Stocks To Watch to start your Sunday (you can r… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2019-10-03 2019-11-01 2019-10-04 2019-09-11 0.41 No Change QoQ
2019-07-03 2019-08-01 2019-07-05 2019-06-13 0.41 No Change QoQ
2019-04-04 2019-05-01 2019-04-05 2019-03-07 0.41 No Change QoQ
2019-01-03 2019-02-01 2019-01-04 2018-12-06 0.41 Increase
2018-10-04 2018-11-01 2018-10-05 2018-09-12 0.4 No Change QoQ
2018-07-05 2018-08-01 2018-07-06 2018-06-14 0.4 No Change QoQ
2018-04-05 2018-05-01 2018-04-06 2018-03-01 0.4 No Change QoQ
2018-01-04 2018-02-01 2018-01-05 2017-12-07 0.4 Increase
2017-10-05 2017-11-01 2017-10-06 2017-09-13 0.39 No Change QoQ
2017-07-05 2017-08-01 2017-07-07 2017-06-13 0.39 No Change QoQ
2017-04-05 2017-05-01 2017-04-07 2017-03-02 0.39 No Change QoQ
2017-01-04 2017-02-01 2017-01-06 2016-12-08 0.39 Increase
2016-10-05 2016-11-01 2016-10-07 2016-08-03 0.38 No Change QoQ
2016-06-29 2016-08-01 2016-07-01 2016-06-07 0.38 No Change QoQ
2016-03-30 2016-05-02 2016-04-01 2016-03-03 0.38 No Change QoQ
2015-12-30 2016-02-01 2016-01-04 2015-12-08 0.38 Increase
2015-09-30 2015-11-02 2015-10-02 2015-09-17 0.37 No Change QoQ
2015-07-01 2015-08-03 2015-07-06 2015-06-16 0.37 No Change QoQ
2015-04-01 2015-05-01 2015-04-06 2015-03-02 0.37 No Change QoQ
2014-12-30 2015-02-02 2015-01-02 2014-12-09 0.37 Increase
2014-10-01 2014-11-03 2014-10-03 2014-09-16 0.36 No Change QoQ
2019-10-03 2019-11-01 2019-10-04 2019-09-11 0.41 Cash
2020-01-02 2020-02-03 2020-01-03 2019-12-05 0.45 Cash
2020-04-02 2020-05-01 2020-04-03 2020-03-02 0.45 Cash
2020-07-02 2020-08-03 2020-07-06 2020-06-11 0.45 Cash
2020-10-01 2020-11-02 2020-10-02 2020-09-10 0.45 Cash
2020-12-31 2021-02-01 2021-01-04 2020-12-10 0.49 Cash
2021-03-31 2021-05-03 2021-04-01 2021-03-01 0.49 Cash
2021-07-01 2021-08-02 2021-07-02 2021-06-17 0.49 Cash
2021-09-30 2021-11-01 2021-10-01 2021-09-09 0.49 Cash
2022-01-06 2022-02-01 2022-01-07 2021-12-13 0.54 Cash
2022-03-31 2022-05-02 2022-04-01 2022-03-01 0.54 Cash
2022-06-30 2022-08-01 2022-07-01 2022-06-15 0.54 Cash
2022-10-06 2022-11-01 2022-10-07 2022-09-14 0.54 Cash
2023-01-05 2023-02-01 2023-01-06 2022-12-08 0.57 Cash
2023-04-06 2023-05-01 2023-04-10 2023-03-03 0.57 Cash
2023-07-06 2023-08-01 2023-07-07 2023-06-14 0.57 Cash
2023-10-05 2023-11-01 2023-10-06 2023-09-20 0.57 Cash
2024-01-04 2024-02-01 2024-01-05 2023-12-06 0.6 Cash
2024-04-04 2024-05-01 2024-04-05 2024-03-01 0.6 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud